Positive and negative regulation of EAAT2 by NF-κB: A role for N-myc in TNFα-controlled repression

EMBO Journal

Volumn 24, Issue 3, 2005, Pages 510-520

  Sitcheran, Raquel ^a   Gupta, Pankaj ^b   Fisher, Paul B ^b   Baldwin, Albert S ^a,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Columbia University Medical Center ^*  (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

EAAT2; EGF; N myc; NF b; TNF

Indexed keywords

EPIDERMAL GROWTH FACTOR; GLUTAMATE TRANSPORTER; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTOMA CELL; BINDING SITE; CHROMATIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; EAAT2 GENE; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION REGULATION; GENE REPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

AMINO ACID TRANSPORT SYSTEM X-AG; BASE SEQUENCE; CELL LINE; DNA; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SYMPORTERS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14844316278     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600555     Document Type: Article

References (48)

1. Amrolia PJ, Cunningham JM, Ney P, Nienhuis AW, Jane SM (1995) Identification of two novel regulatory elements within the 5′-untranslated region of the human A gamma-globin gene. J Biol Chem. 270: 12892-12898
2. Anest V, Cogswell PC, Baldwin AS (2004) IKKalpha and p65/RelA contribute to optimal EGF-induced c-fos gene expression independent of Ikappa Balpha degradation. J Biol Chem 279: 31183-31189
3. Baldwin AS (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107: 241-246
4. Banan A, Zhang LJ, Farhadi A, Fields JZ, Shaikh M, Keshavarzian A (2004a) PKC-beta1 isoform activation is required for EGF-induced NF-kappaB inactivation and IkappaBalpha stabilization and protection of F-actin assembly and barrier function in enterocyte monolayers. Am J Physiol Cell Physiol 286: C723-C738
5. Banan A, Zhang LJ, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A (2004b) Inhibition of oxidant-induced nuclear factor-kappaB activation and inhibitory-kappaBalpha degradation and instability of F-actin cytoskeletal dynamics and barrier function by epidermal growth factor: key role of phospholipase-gamma isoform. J Pharmacol Exp Ther 309: 356-368
6. Belvin MP, Anderson KV (1996) A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol 12: 393-416
7. Biswas DK, Cruz AP, Gansberger E, Pardee AB (2000) Epidermal growth factor-induced nuclear factor kappa B activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci USA 97: 8542-8547
8. Campbell KJ, Rocha S, Perkins ND (2004) Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13: 853-865
9. Chen D, Xu LG, Chen L, Li L, Zhai Z, Shu HB (2003) NIK is a component of the EGF/heregulin receptor signaling complexes. Oncogene 22: 4348-4355
10. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634
11. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65: 1-105
12. Doble A (1999) The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol Ther 81: 163-221
13. Ferrer I, Blanco R (2000) N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. Brain Res Mol Brain Res 77: 270-276
14. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl): S81-S96
15. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M, Kikugawa K (2003) Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22: 3356-3366
16. Hong CY, Park JH, Seo KH, Kim JM, Im SY, Lee JW, Choi HS, Lee K (2003) Expression of MIS in the testis is downregulated by tumor necrosis factor alpha through the negative regulation of SF-1 transactivation by NF-kappa B. Mol Cell Biol 23: 6000-6012
17. Israel A (2000) The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol 10: 129-133
18. Jones KA, Luciw PA, Duchange N (1988) Structural arrangements of transcription control domains within the 5′-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev 2: 1101-1114
19. Knoepfler PS, Cheng PF, Eisenman RN (2002) N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 16: 2699-2712
20. Kornblum HI, Hussain R, Wiesen J, Miettinen P, Zurcher SD, Chow K, Derynck R, Werb Z (1998) Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor. J Neurosci Res 53: 697-717
21. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734
22. Mansour SL, Grodzicker T, Tjian R (1986) Downstream sequences affect transcription initiation from the adenovirus major late promoter. Mol Cell Biol 6: 2684-2694
23. Maragakis NJ, Dykes-Hoberg M, Rothstein JD (2004) Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann Neurol 55: 469-477
24. Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, Luscombe NM, Rinn JL, Nelson FK, Miller P, Gerstein M, Weissman S, Snyder M (2003) Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci USA 100: 12247-12252
25. Mattson MP, Camandola S (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107: 247-254
26. Mayo MW, Norris JL, Baldwin AS (2001) Ras regulation of NF-kappa B and apoptosis. Methods Enzymol 333: 73-87
27. Mehta VB, Besner GE (2003) Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor. J Immunol 171: 6014-6022
28. O'Neill LA, Kaltschmidt C (1997) NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20: 252-258
29. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686
30. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Hoberg MD, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su Z-z, Gupta P, Fisher PB (2004) B Lactam antibiotics increase neurotransmitter glutamate transporter expression and function by gene activation. Nature 433: 73-77
31. Sato M, Miyazaki T, Nagaya T, Murata Y, Ida N, Maeda K, Seo H (1996) Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells. J Rheumatol 23: 432-438
32. Sawai S, Shimono A, Hanaoka K, Kondoh H (1991) Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. New Biol 3: 861-869
33. Schluter K, Figiel M, Rozyczka J, Engele J (2002) CNS region-specific regulation of glial glutamate transporter expression. Eur J Neurosci 16: 836-842
34. Schreck R, Grassmann R, Fleckenstein B, Baeuerle PA (1992) Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein. J Virol 66: 6288-6293
35. Schwab M (1993) Amplification of N-myc as a prognostic marker for patients with neuroblastoma. Semin Cancer Biol 4: 13-18
36. Silverman N, Maniatis T (2001) NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev 15: 2321-2342
37. Sitcheran R, Cogswell PC, Baldwin Jr AS (2003) NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev 17: 2368-2373
38. Soustelle L, Besson MT, Rival T, Birman S (2002) Terminal glial differentiation involves regulated expression of the excitatory amino acid transporters in the Drosophila embryonic CNS. Dev Biol 248: 294-306
39. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF (1992) Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 6: 2235-2247
40. Su ZZ, Leszczyniecka M, Kang DC, Sarkar D, Chao W, Volsky DJ, Fisher PB (2003) Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2). Proc Natl Acad Sci USA 100: 1955-1960
41. Sun L, Carpenter G (1998) Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium. Oncogene 16: 2095-2102
42. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276: 1699-1702
43. Trotti D (2002) A role for glutamate transporters in neurodegenerative diseases. Adv Exp Med Biol 513: 225-248
44. Valhmu WB, Palmer GD, Dobson J, Fischer SG, Ratcliffe A (1998) Regulatory activities of the 5′- and 3′-untranslated regions and promoter of the human aggrecan gene. J Biol Chem 273: 6196-6202
45. van't Veer LJ, Beijersbergen RL, Bernards R (1993) N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B. EMBO J 12: 195-200
46. Verrecchia F, Wagner EF, Mauviel A (2002) Distinct involvement of the Jun-N-terminal kinase and NF-kappaB pathways in the repression of the human COL1A2 gene by TNF-alpha. EMBO Rep 3: 1069-1074
47. Yamamoto Y, Gaynor RB (2004) IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 29: 72-79
48. Zelenaia O, Schlag BD, Gochenauer GE, Ganel R, Song W, Beesley JS, Grinspan JB, Rothstein JD, Robinson MB (2000) Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB. Mol Pharmacol 57: 667-678